香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Beauty Farm Medical and Health Industry Inc. 美麗田園醫療健康產業有限公司 * （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：2373） 自願公告 市場股份回購 本公司董事（「董事」）會（「董事會」）認為，目前的股份成交價並不反映股份的內在價 值和本公司的實際業務前景。董事會相信，股份購回體現了管理層對企業長期價值 的堅定信心，有利於提升本集團資本市場價值及股東回報能力。本次股份購回符合 本公司及其股東的整體利益。 董事會本次回購是通過於2025年6月27日舉行的本公司股東週年大會（「股東週年大 會」）通過的股東（「股東」）決議案取得購回本公司股份（「股份」）的一般授權（「購回授 權」）進行。根據購回授權，本公司可購回最多23,579,556股股份，佔股東週年大會 日期已發行股份數目的10%。 * 僅供識別 – 1 – 本公告由 ...

Summary of Key Points Core Viewpoint - On October 27, 34 Hong Kong-listed companies conducted share buybacks, totaling 15.35 million shares and an aggregate amount of HKD 76.77 million, indicating a trend of companies returning capital to shareholders through buybacks [1]. Group 1: Buyback Details - China Feihe repurchased 5.89 million shares for HKD 24.07 million, with a highest price of HKD 4.09 and a lowest price of HKD 4.08, accumulating HKD 57.07 million in buybacks for the year [1][2]. - Gushengtang repurchased 244,400 shares for HKD 7.19 million, with a highest price of HKD 29.66 and a lowest price of HKD 29.22, totaling HKD 256.39 million in buybacks for the year [1][2]. - Mengniu Dairy repurchased 400,000 shares for HKD 5.77 million, with a highest price of HKD 14.46 and a lowest price of HKD 14.38, accumulating HKD 480 million in buybacks for the year [1][2]. Group 2: Buyback Rankings - The highest buyback amount on October 27 was by China Feihe at HKD 24.07 million, followed by Gushengtang at HKD 7.19 million, and Mengniu Dairy among the top [1][2]. - In terms of share quantity, China Feihe led with 5.89 million shares repurchased, followed by Chenxun Technology and Lianyi Technology-W with 1.45 million and 1.16 million shares, respectively [1][2]. Group 3: Additional Buyback Information - The buyback by Puleshi Group Holdings was noted as its first for the year, while Mengniu Dairy has conducted multiple buybacks totaling HKD 480 million [2]. - A detailed table of buybacks on October 27 includes various companies, their respective buyback shares, amounts, highest and lowest prices, and cumulative buyback amounts for the year [2][3].

Summary of Key Points Core Viewpoint - A total of 30 companies conducted share buybacks on October 27, 2025, with China Feihe (06186) leading in both the number of shares repurchased and the total amount spent on buybacks. Group 1: Buyback Details - China Feihe (06186) repurchased 5.886 million shares for a total of 24.0721 million yuan, representing 0.152% of its total share capital with a year-to-date total of 13.771 million shares repurchased [1][2] - Guosheng Tang (02273) repurchased 244,400 shares for 7.1899 million yuan, with a year-to-date total of 5.5026 million shares, accounting for 2.322% of its total share capital [2] - Mengniu Dairy (02319) repurchased 400,000 shares for 5.7710 million yuan, with a year-to-date total of 21.716 million shares, representing 0.555% of its total share capital [2] Group 2: Other Notable Buybacks - Lianlian Digital (02598) repurchased 711,000 shares for 5.7458 million yuan, with a year-to-date total of 2.5925 million shares, accounting for 0.620% of its total share capital [2] - Zhongxu Future (09890) repurchased 345,200 shares for 5.0690 million yuan, with a year-to-date total of 647,400 shares, representing 1.210% of its total share capital [2] - Kangchen Pharmaceutical (01681) repurchased 100,000 shares for 1.5400 million yuan, with a year-to-date total of 740,600 shares, accounting for 8.700% of its total share capital [2][3]

Group 1 - The non-executive director Yi Lin increased his stake in Beautiful Farm Medical Health (02373) by purchasing 30,000 shares at a price of HKD 29.82 per share, totaling HKD 894,600 [1] - After the purchase, the total number of shares held by Yi Lin is 30,000, representing a holding percentage of 0.01% [1]

Core Viewpoint - Meili Tianyuan Healthcare (02373) announced a share buyback of 40,000 shares on October 27, 2025, for a total consideration of approximately HKD 1.2441 million, with an average transaction price of about HKD 31.10 per share [1] Summary by Category - **Share Buyback Activity** - The company has repurchased a total of 415,000 shares from October 15, 2025, to the date of the announcement, with a total consideration of approximately HKD 13.2249 million [1]

智通财经APP讯，美丽田园医疗健康(02373)发布公告，本公司于2025年10月27日于市场购回4万股本公 司股份，总交易金额约124.41万港元，交易平均价约每股31.10港元。自2025年10月15日至本公告日期止 期间，本公司已购回共41.5万股股份，总对价约1322.49万港元。 ...

Core Viewpoint - The company, 美丽田园医疗健康 (02373.HK), has repurchased shares, indicating management's confidence in the long-term value of the business and aiming to enhance shareholder returns [1] Summary by Relevant Sections Share Buyback Details - On October 27, 2025, the company repurchased 40,000 shares at a total transaction amount of approximately HKD 1,244,090, with an average price of about HKD 31.10 per share [1] - From October 15, 2025, to the date of the announcement, the company has repurchased a total of 415,000 shares for approximately HKD 13,224,850 [1] Management's Perspective - The board believes that the current share price does not reflect the intrinsic value of the shares and the actual business prospects of the company [1] - The share buyback is seen as beneficial for the overall interests of the company and its shareholders, reinforcing management's commitment to the company's long-term value [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 美麗田園醫療健康產業有限公司 呈交日期： 2025年10月27日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 不適用 | | 於香港聯交所上市 | 是 | | | 證券代號 (如上市) | 02373 | 說明 | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | 庫存股份變動 | | | | | 事件 | 已發行股份（不包括庫存股份）數 目 | 佔有關事件前的現有已發 行股份（ ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Beauty Farm Medical and Health Industry Inc. 美麗田園醫療健康產業有限公司 * （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：2373） 自願公告 市場股份回購 本公告由美麗田園醫療健康產業有限公司（「本公司」，連同其附屬公司統稱「本集 團」）自願刊發。 本公司董事（「董事」）會（「董事會」）認為，目前的股份成交價並不反映股份的內在價 值和本公司的實際業務前景。董事會相信，股份購回體現了管理層對企業長期價值 的堅定信心，有利於提升本集團資本市場價值及股東回報能力。本次股份購回符合 本公司及其股東的整體利益。 董事會本次回購是通過於2025年6月27日舉行的本公司股東週年大會（「股東週年大 會」）通過的股東（「股東」）決議案取得購回本公司股份（「股份」）的一般授權（「購回授 權」）進行。根據購回授權，本公司可購回最多23,579, ...

Core Viewpoint - Multiple companies, including China Feihe and Lianyi Rong Technology, conducted share buybacks on October 24, 2025, with China Feihe leading in both the number of shares repurchased and the total amount spent [1][2]. Group 1: Buyback Details - China Feihe (06186) repurchased 5.885 million shares for a total of 23.6977 million yuan, representing 0.087% of its total share capital [2]. - Lianyi Rong Technology (09959) repurchased 2.4 million shares for 7.3782 million yuan, accounting for 3.516% of its total share capital [2]. - Beike-W (02423) repurchased 1.1784 million shares for 7 million yuan, which is 1.722% of its total share capital [2]. Group 2: Other Notable Buybacks - Yum China (09987) repurchased 17,800 shares for 6.2549 million yuan, representing 2.830% of its total share capital [2]. - Mengniu Dairy (02319) repurchased 400,000 shares for 5.7447 million yuan, which is 0.545% of its total share capital [2]. - Kangsong Pharmaceutical (01681) repurchased 100,000 shares for 1.5180 million yuan, accounting for 8.582% of its total share capital [2].